Calidi Biotherapeutics, Inc. (CLDI)
USD 0.42
(-15.34%)
USD 0.42
(-15.34%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -28.99 Million USD | -25.35% |
| 2022 | -23.12 Million USD | -1198.09% |
| 2021 | -1.78 Million USD | 73.69% |
| 2020 | -6.77 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.77 Million USD | 14.51% |
| 2024 Q1 | -6.75 Million USD | 31.24% |
| 2023 Q4 | -9.82 Million USD | -35.99% |
| 2023 FY | -28.99 Million USD | -25.35% |
| 2023 Q3 | -7.22 Million USD | -382.77% |
| 2023 Q2 | -1.49 Million USD | 26.29% |
| 2023 Q1 | -2.02 Million USD | 25.25% |
| 2022 Q1 | -528.86 Thousand USD | 12.37% |
| 2022 Q4 | -2.71 Million USD | -155.08% |
| 2022 Q3 | -1.06 Million USD | -194.31% |
| 2022 FY | -23.12 Million USD | -1198.09% |
| 2022 Q2 | -361.62 Thousand USD | 31.62% |
| 2021 Q3 | -1.09 Million USD | 0.0% |
| 2021 FY | -1.78 Million USD | 73.69% |
| 2021 Q4 | -603.52 Thousand USD | 44.88% |
| 2020 FY | -6.77 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -31.91 Million USD | 9.162% |
| Ampio Pharmaceuticals, Inc. | -9.51 Million USD | -204.602% |
| Armata Pharmaceuticals, Inc. | -40.89 Million USD | 29.098% |
| Actinium Pharmaceuticals, Inc. | -51.92 Million USD | 44.16% |
| Azitra, Inc. | -7.61 Million USD | -280.653% |
| Can-Fite BioPharma Ltd. | -8.19 Million USD | -253.777% |
| Chromocell Therapeutics Corporation | -6.86 Million USD | -322.483% |
| CEL-SCI Corporation | -31.47 Million USD | 7.892% |
| iBio, Inc. | -16.63 Million USD | -74.294% |
| Lineage Cell Therapeutics, Inc. | -24.73 Million USD | -17.22% |
| MAIA Biotechnology, Inc. | -20.18 Million USD | -43.65% |
| Matinas BioPharma Holdings, Inc. | -23.76 Million USD | -21.989% |
| Navidea Biopharmaceuticals, Inc. | -14.05 Million USD | -106.336% |
| NovaBay Pharmaceuticals, Inc. | -5 Million USD | -479.492% |
| NanoViricides, Inc. | -8.51 Million USD | -240.437% |
| Oragenics, Inc. | -20.9 Million USD | -38.685% |
| BiomX Inc. | -27.68 Million USD | -4.721% |
| BiomX Inc. | -27.68 Million USD | -4.721% |
| Protalix BioTherapeutics, Inc. | 10.46 Million USD | 377.17% |
| Palatin Technologies, Inc. | -22.49 Million USD | -28.876% |
| Scorpius Holdings, Inc. | -42.03 Million USD | 31.024% |
| Theriva Biologics, Inc. | -21.43 Million USD | -35.281% |